Shilpa Medicare is a specialty pharma company focused on oncology APIs, formulations, biologics, and CDMO business. The company is gradually improving its operational performance with strong focus on regulated markets.
Key Financial Ratios
ROE: Improving trend indicates better capital efficiency
ROCE: Healthy operational performance improvement
Debt to Equity: Manageable debt levels support expansion plans
Promoter Holding: Stable promoter confidence
Operating Margins: Recovering due to better product mix
R&D Focus: Strong pipeline support for long-term growth
Technical Analysis
SHILPAMED has formed a large Rectangle Pattern on the weekly timeframe, indicating long-term consolidation and accumulation.
The stock is currently approaching the key breakout resistance near ₹500. A strong weekly close above this level with volume expansion could trigger fresh bullish momentum.
Important technical levels to watch:
Major Breakout Zone: ₹500
Target 1: ₹556
Target 2: ₹710
Long-Term Target: ₹845
Strong Reversal Zone: ₹363–₹415
Major Support: ₹260–₹280
Outlook
The recent bounce from the reversal zone reflects strong buying interest. As long as the stock sustains above ₹363, the broader bullish structure remains intact. A confirmed breakout above ₹500 may open the path for the next major upward move.
Disclaimer: aliceblueonline.com/legal-documentation/disclaimer/
Key Financial Ratios
ROE: Improving trend indicates better capital efficiency
ROCE: Healthy operational performance improvement
Debt to Equity: Manageable debt levels support expansion plans
Promoter Holding: Stable promoter confidence
Operating Margins: Recovering due to better product mix
R&D Focus: Strong pipeline support for long-term growth
Technical Analysis
SHILPAMED has formed a large Rectangle Pattern on the weekly timeframe, indicating long-term consolidation and accumulation.
The stock is currently approaching the key breakout resistance near ₹500. A strong weekly close above this level with volume expansion could trigger fresh bullish momentum.
Important technical levels to watch:
Major Breakout Zone: ₹500
Target 1: ₹556
Target 2: ₹710
Long-Term Target: ₹845
Strong Reversal Zone: ₹363–₹415
Major Support: ₹260–₹280
Outlook
The recent bounce from the reversal zone reflects strong buying interest. As long as the stock sustains above ₹363, the broader bullish structure remains intact. A confirmed breakout above ₹500 may open the path for the next major upward move.
Disclaimer: aliceblueonline.com/legal-documentation/disclaimer/
คำจำกัดสิทธิ์ความรับผิดชอบ
ข้อมูลและบทความไม่ได้มีวัตถุประสงค์เพื่อก่อให้เกิดกิจกรรมทางการเงิน, การลงทุน, การซื้อขาย, ข้อเสนอแนะ หรือคำแนะนำประเภทอื่น ๆ ที่ให้หรือรับรองโดย TradingView อ่านเพิ่มเติมใน ข้อกำหนดการใช้งาน
คำจำกัดสิทธิ์ความรับผิดชอบ
ข้อมูลและบทความไม่ได้มีวัตถุประสงค์เพื่อก่อให้เกิดกิจกรรมทางการเงิน, การลงทุน, การซื้อขาย, ข้อเสนอแนะ หรือคำแนะนำประเภทอื่น ๆ ที่ให้หรือรับรองโดย TradingView อ่านเพิ่มเติมใน ข้อกำหนดการใช้งาน